Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors

• 1. 使用PI3K/MTOR的吡啶并嘧啶酮抑制剂与苯达莫司汀和/或利妥昔单抗治疗恶性血液病的组合疗法 [P] . 中国专利： CN103874494A . 2014-06-18
• 2. 使用PI3K/MTOR的吡啶并嘧啶抑制剂来治疗淋巴瘤的方法 [P] . 中国专利： CN103635183A . 2014-03-12
• 3. Methods of Treating Cancer Using Pyridopyrimidinone Inhibitors of PI3K and mTOR in Combination with Autophagy Inhibitors [P] . 美国专利： US2013172371A1 . 2013-07-04

  机译： PI3K和mTOR的嘧啶嘧啶酮抑制剂与自噬抑制剂联合治疗癌症的方法

• 4. METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K AND MTOR IN COMBINATION WITH AUTOPHAGY INHIBITORS [P] . 世界知识产权组织专利： WO2011100319A1 . 2011-08-18

  机译： PI3K和MTOR的吡啶并嘧啶酮抑制剂与自噬抑制剂联合治疗癌症的方法

• 5. Methods for treating cancer using PI3K and mTOR inhibitors in combination with inhibitors of autophagy [P] . UY33221A . 2011-09-30

  机译： 使用PI3K和mTOR抑制剂与自噬抑制剂联合治疗癌症的方法

• 1. PI3K/Akt/mTOR inhibitors in breast cancer [J] . Joycelyn JX Lee, Kiley Loh, Yoon-Sim Yap 癌症生物学与医学：英文版 . 2015,第004期
• 2. PI3K/Akt/mTOR inhibitors in breast cancer [J] . Joycelyn JX Lee, Kiley Loh, Yoon-Sim Yap 癌症生物学与医学（英文版 ） . 2015,第004期
• 3. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells [J] . MartinelliE., TroianiT., DAiutoE., International Journal of Cancer =: Journal International du Cancer . 2013,第9期
• 4. alpha-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice [J] . Wang Fei, Ma Hongxia, Liu Zhaoguo, Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie . 2017,第期
• 5. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells [J] . Hong-Wei Zhang, Jin-Jiao Hu, Ruo-Qiu Fu, Scientific reports. . 2018,第1期
• 6. Label-free phosphoproteomics method to investigate signaling pathways downstream of novel PI3K/mTOR inhibitors in cancer cells [C] . Pedro Casado, Juan Carlos Rodriguez-Prados, Sabina Cosulich, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011
• 7. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-Clinical Mechanistic Assessment [D] . Moorthy, Ganesh P. 2015
• 8. Discovery of Pyridopyrimidinones as Potent and OrallyActive Dual Inhibitors of PI3K/mTOR [O] . Tao Yu, *, Ning Li, 2018
• 9. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells [O] . Martinelli Erika, Troiani Teresa, DAiuto Elena, 2013

• 1. The Heat Shock Protein Story—From Taking mTORC1,2 and Heat Shock Protein Inhibitors as Therapeutic Measures for Treating Cancers to Development of Cancer Vaccines [J] . Peter Chin Wan Fung ,Regina Kit Chee Kong . 癌症治疗（英文） . 2017,第11期
• 2. Zn-doped CuO nanocomposites inhibit in vitro and in vivo growth of pancreatic cancer by inducing autophagy through AMPK/mTOR pathway [J] . Xiao LI ,Huan-li XU ,Ye TIAN . 中国药理学与毒理学杂志 . 2018,第004期
• 3. Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway [J] . Yuzhen Zhu ,Yu Zhong ,Yu Zhou . 中医（英文） . 2018,第3期
• 4. PI3K抑制剂联合奥沙利铂/氟尿嘧啶对人结肠癌HT-29细胞生长的抑制作用 [C] . 赵长林 ,袁俊波 ,杨云琳 . 第十五届全国临床肿瘤学大会暨2012年CSCO学术年会 . 2012
• 5. 吡唑并[3,4-d]嘧啶类mTOR/PI3K抑制剂的合成研究 [A] . 罗文隆 . 2012